Published in Lancet on August 08, 1987
Testicular cancer and related neoplasms. BMJ (1992) 1.66
Frequency of serum tumour marker monitoring in patients with non-seminomatous germ cell tumours. Br J Cancer (1990) 1.39
Influence of delay in diagnosis on prognosis in testicular teratoma. Br J Cancer (1989) 1.09
Surveillance following orchidectomy for stage I testicular seminoma. Br J Cancer (1992) 1.03
Evidence-based pragmatic guidelines for the follow-up of testicular cancer: optimising the detection of relapse. Br J Cancer (2008) 1.01
Canadian consensus guidelines for the management of testicular germ cell cancer. Can Urol Assoc J (2010) 0.92
Results of treatment of non seminomatous germ cell tumours; 122 consecutive cases in the West of Scotland, 1981-1985. Br J Cancer (1988) 0.90
High-risk clinical stage I nonseminomatous germ cell tumors: the case for chemotherapy. World J Urol (2009) 0.89
Imaging of testicular germ cell tumours. Cancer Imaging (2006) 0.87
Management preferences in stage I non-seminomatous germ cell tumours of the testis: an investigation among patients, controls and oncologists. Br J Cancer (1996) 0.86
Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17). Br J Cancer (2005) 0.83
How safe is surveillance in patients with histologically low-risk non-seminomatous testicular cancer in a geographically extended country with limited computerised tomographic resources? Br J Cancer (1994) 0.80
Surveillance for patients with clinical stage I nonseminomatous testicular germ cell tumors. World J Urol (2014) 0.77
Dimethyl sulfoxide induces chemotherapeutic resistance in the treatment of testicular embryonal carcinomas. Oncol Lett (2015) 0.77
Handling and reporting of orchidectomy specimens with testicular cancer: areas of consensus and variation among 25 experts and 225 European pathologists. Histopathology (2015) 0.75
Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumours. J Transl Med (2017) 0.75
Prostatic relapse of an undifferentiated teratoma 24 years after orchidectomy. BMC Res Notes (2015) 0.75
An analysis of surveillance for stage I combined teratoma--seminoma of the testis. Br J Cancer (1996) 0.75
Current update of management of clinical stage I non seminomatous germ cell tumors of testis. Indian J Surg Oncol (2012) 0.75
Testicular carcinoma. Postgrad Med J (1997) 0.75
Management options for stage 1 nonseminomatous germ cell tumors of the testis. Indian J Urol (2010) 0.75
The management of low-stage non-seminomatous germ cell tumors. Oncol Rev (2012) 0.75
Surveillance in testicular cancer: who, when, what and how? Cancer Imaging (2007) 0.75
Rapid progression of a germ cell tumor encasing the inferior vena cava and aorta following a radical orchiectomy. Rare Tumors (2013) 0.75
Current Concepts in Management of Stage I NSGCT. Indian J Surg Oncol (2016) 0.75
Optimal management of testicular cancer: from self-examination to treatment of advanced disease. Open Access J Urol (2010) 0.75
[Testicular tumors. Predictive factors]. Pathologe (2008) 0.75
Design and serendipity in establishing a large cohort with wide dietary intake distributions : the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol (2001) 11.17
Breast cancer clusters in the northeast United States: a geographic analysis. Am J Epidemiol (1997) 5.73
Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet (2001) 5.71
Tables of the number of patients required in clinical trials using the logrank test. Stat Med (1983) 5.34
Allocation of patients to treatment groups in a controlled clinical study. Br J Cancer (1978) 5.25
Usefulness of letters from hospitals to general practitioners. Br Med J (Clin Res Ed) (1984) 4.01
On the use of Pocock and Simon's method for balancing treatment numbers over prognostic factors in the controlled clinical trial. Biometrics (1976) 3.82
Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res (1978) 3.51
Variability in automatic activation as an unobtrusive measure of racial attitudes: a bona fide pipeline? J Pers Soc Psychol (1995) 3.14
Combined management of malignant teratoma of the testis. Lancet (1979) 3.12
Familial testicular cancer: a report of the UK family register, estimation of risk and an HLA class 1 sib-pair analysis. Br J Cancer (1992) 3.10
Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst (1996) 2.98
In vitro and in vivo radiosensitivity of human tumour cells obtained from a pancreatic carcinoma xenograft. Nature (1976) 2.77
Internal deletion in a collagen gene in a perinatal lethal form of osteogenesis imperfecta. Nature (1983) 2.73
Investigation, treatment and prognosis of bronchial carcinoma in the Yorkshire Region of England 1976-1983. Br J Cancer (1990) 2.68
Macrophage inflammatory protein 1 modulates macrophage function. J Immunol (1992) 2.66
Exploitable mechanisms in combined radiotherapy-chemotherapy: the concept of additivity. Int J Radiat Oncol Biol Phys (1979) 2.63
Rapid diagnosis of testicular tumour. Br J Hosp Med (1992) 2.54
Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II. Cancer Chemother Pharmacol (1982) 2.50
Implications of a new dietary measurement error model for estimation of relative risk: application to four calibration studies. Am J Epidemiol (1999) 2.40
Empirical evidence of correlated biases in dietary assessment instruments and its implications. Am J Epidemiol (2001) 2.33
V(D)J recombination activates a p53-dependent DNA damage checkpoint in scid lymphocyte precursors. Genes Dev (1996) 2.29
Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group. J Clin Oncol (1997) 2.29
A collaborative scheme for tissue typing and matching in renal transplantation. Lancet (1969) 2.26
Optimal planning target volume for stage I testicular seminoma: A Medical Research Council randomized trial. Medical Research Council Testicular Tumor Working Group. J Clin Oncol (1999) 2.25
Injuries sustained on "bouncy castles". BMJ (1992) 2.20
Evidence against either a premature stop codon or the absence of obese gene mRNA in human obesity. J Clin Invest (1995) 2.20
Temozolomide: a new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours. Eur J Cancer (1993) 2.18
Choriocarcinoma and partial hydatidiform moles. Lancet (2000) 2.15
Prospective study of follow up alone in stage I teratoma of the testis. Br Med J (Clin Res Ed) (1983) 2.13
High dose epirubicin is effective in measurable metastatic prostate cancer: a phase II study of the EORTC Genitourinary Group. Eur J Cancer (1995) 2.10
Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. J Clin Oncol (2002) 2.06
EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients. J Clin Oncol (1997) 2.00
Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy. Lancet (1991) 1.95
Delay in diagnosing testicular tumours. Br Med J (Clin Res Ed) (1985) 1.94
Hematologic neoplasia in patients treated for Hodgkin's disease. N Engl J Med (1977) 1.93
Histological grade and other prognostic factors in relation to survival of patients with breast cancer. Br J Cancer (1979) 1.92
The CHART trials: Bayesian design and monitoring in practice. CHART Steering Committee. Stat Med (1994) 1.90
Orchiectomy alone for Stage I testicular non-seminoma. A progress report on the Royal Marsden Hospital study. Br J Urol (1983) 1.87
The interpretation of marker protein assays: a critical appraisal in clinical studies and a xenograft model. Br J Cancer Suppl (1980) 1.85
Potential impact of genetic testing on cancer prevention trials, using breast cancer as an example. J Natl Cancer Inst (1995) 1.84
The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP). Br J Cancer (1983) 1.84
Treatment of advanced localised prostatic cancer by orchiectomy, radiotherapy, or combined treatment. A Medical Research Council Study. Urological Cancer Working Party--Subgroup on Prostatic Cancer. Br J Urol (1992) 1.83
A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinion. Stat Med (1986) 1.82
Genetic determinants of bone mass in adult women: a reevaluation of the twin model and the potential importance of gene interaction on heritability estimates. J Bone Miner Res (1991) 1.82
Further advances in the management of malignant teratomas of the testis and other sites. Lancet (1983) 1.80
Effect of age at orchidopexy on risk of testicular cancer. Lancet (1986) 1.80
Variation in response of xenografts of colo-rectal carcinoma to chemotherapy. Br J Cancer (1978) 1.77
ACP Broadsheet No 146: August 1995. Macroscopic examination of prostatic specimens. J Clin Pathol (1995) 1.76
Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy. Br J Cancer (2000) 1.74
Rare cancers and specialist centres. Br Med J (Clin Res Ed) (1986) 1.73
Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party. J Clin Oncol (1992) 1.73
Synthesis and processing of a type I procollagen containing shortened pro-alpha 1(I) chains by fibroblasts from a patient with osteogenesis imperfecta. J Biol Chem (1983) 1.71
Phase I trial of temozolomide using an extended continuous oral schedule. Cancer Res (1998) 1.70
The radioresponsiveness of human tumours and the initial slope of the cell survival curve. Radiother Oncol (1984) 1.68
Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma. Cancer Chemother Pharmacol (1997) 1.68
The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working Party. J Clin Oncol (1992) 1.67
Multiexon deletion in an osteogenesis imperfecta variant with increased type III collagen mRNA. J Biol Chem (1985) 1.67
Treatment with gonadotrophin releasing hormone analogue in advanced prostatic cancer. Br Med J (Clin Res Ed) (1983) 1.67
Audit: the use of radiotherapy for NSCLC in the UK. Clin Oncol (R Coll Radiol) (1993) 1.67
Surveillance for stage I testicular germ cell tumours: results and cost benefit analysis of management options. Eur J Cancer (2000) 1.66
Monitoring mRNA decapping activity. Methods (1999) 1.64
The human tumour xenograft--a valid model in experimental chemotherapy? Br J Surg (1980) 1.63
The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up. J Urol (1996) 1.63
Interpreting precursor studies: what polyp trials tell us about large-bowel cancer. J Natl Cancer Inst (1994) 1.61
Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma. J Clin Oncol (1995) 1.61
Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells. Br J Cancer (1993) 1.60
Evaluation of dietary influences on Escherichia coli O157:H7 shedding by sheep. Appl Environ Microbiol (1997) 1.60
Orchidectomy alone in testicular stage I non-seminomatous germ-cell tumours. Lancet (1982) 1.58
Can energy adjustment separate the effects of energy from those of specific macronutrients? Am J Epidemiol (1994) 1.56
CT assessment of tumour response to treatment: comparison of linear, cross-sectional and volumetric measures of tumour size. Br J Radiol (2000) 1.55
Agents that release histamine from mast cells. Annu Rev Pharmacol Toxicol (1983) 1.55
Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapy. Eur J Cancer (1997) 1.55
Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors. J Clin Oncol (1996) 1.54
Cytokine production in a model of wound healing: the appearance of MIP-1, MIP-2, cachectin/TNF and IL-1. Cytokine (1990) 1.53
The response to chemotherapy of a variety of human tumour xenografts. Br J Cancer (1983) 1.53
Carboplatin or cisplatin? Lancet (1988) 1.53
Developments in chemotherapy for medium- and high-risk patients with gestational trophoblastic tumours (1979-1984). Br J Obstet Gynaecol (1986) 1.53
Long-term follow-up of non-seminomatous testicular cancer patients with mature teratoma or carcinoma at postchemotherapy surgery. EORTC Genitourinary Tract Cancer Cooperative Group (EORTC GU Group) Eur J Cancer (1991) 1.52
Cisplatin combination chemotherapy versus chlorambucil in advanced ovarian carcinoma: mature results of a randomized trial. J Clin Oncol (1985) 1.51
Attitude accessibility as a moderator of the attitude-perception and attitude-behavior relations: an investigation of the 1984 presidential election. J Pers Soc Psychol (1986) 1.51
Consultants' communications with general practitioners. BMJ (1992) 1.50
Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. The basis for a prognostic index. Cancer (1991) 1.49
The use of a Kolmogorov--Smirnov type statistic in testing hypotheses about seasonal variation. J Epidemiol Community Health (1979) 1.49
Salivary testosterone levels and major depressive illness in men. Br J Psychiatry (1992) 1.49
Phase I clinical trial of mitozolomide. Cancer Treat Rep (1985) 1.48
Chemotherapy for ovarian germ cell tumours. Eur J Cancer (1996) 1.48
Current optimum management of anaplastic germ cell tumours of the testis and other sites. Br J Urol (1986) 1.48
Necrosis of nasal and airway epithelium in rats inhaling vapors of artificial butter flavoring. Toxicol Appl Pharmacol (2002) 1.47
Nodular regenerative hyperplasia of the liver in Felty's syndrome. Q J Med (1974) 1.47
Non-seminoma germ cell tumours (malignant teratoma) of the testis. Results of treatment and an analysis of prognostic factors. Br J Urol (1981) 1.46
Growth of human tumour cell colonies from biopsies using two soft-agar techniques. Br J Cancer (1978) 1.46
Anterior prostate cancer: is it more difficult to diagnose? BJU Int (2002) 1.46
Rapid diagnosis and classification of hydatidiform moles with polymerase chain reaction. Am J Obstet Gynecol (1993) 1.45
Handling and reporting of biopsy and surgical specimens of testicular cancer. Eur Urol (2004) 1.45